Europe — EMA

Pamidronate Disodique Hospira (Pamidronate Disodium)

Pamidronate Disodium, the active ingredient in Pamidronate Disodique Hospira, is a bisphosphonate presented as an injectable solution for intravenous use.

Pamidronate Disodium

Request sourcing

Pack/s

What is Pamidronate Disodium?

Pamidronate Disodium, the active ingredient in Pamidronate Disodique Hospira, is a bisphosphonate presented as an injectable solution for intravenous use. It is used to treat disorders of bone metabolism, particularly in patients with cancer‑related bone disease and in those requiring renal protection during certain imaging procedures.

GNH USA supplies Pamidronate Disodique Hospira as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

What is Pamidronate Disodium used for?

Pamidronate Disodium is employed in several bone‑related clinical pathways, primarily targeting abnormal calcium turnover.

- Hypercalcaemia of malignancy: reduces the elevated serum calcium level. - Bone metastases from solid tumours: helps to lessen bone pain and lower the risk of skeletal‑related events. - Osteolytic lesions in multiple myeloma: stabilises bone structure and reduces fracture risk. - Prevention of renal toxicity during radiopharmaceutical imaging: protects kidney function when certain diagnostic agents are used.

What are the side effects of Pamidronate Disodium?

Adverse reactions to pamidric the immun ...

Common Side Effects: - Fluor g ?. - g . - . - .

Serious or Rare t . - . - . - . - . - .

What precautions apply to Pamidronate Disodium?

Pamidronate g .

t t.

t. - ewline ewline - ewline ewline ewline ewline \n

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →